Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane ...
Morningstar

Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty

Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing ...
Times Argus

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA ® lidocaine range of Restylane ...
Pharmabiz

Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing

Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing: Zug, Switzerland Tuesday, March 24, 2026, 18:00 Hrs [IST] Galderma, the pure-play d ...
Financial Post

Galderma Unveils 'Wake Up To Restylane', Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty

Sorry, your browser doesn't support embedded videos. ZUG, Switzerland — Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To ...